MicroRNA181a enhances the chemotherapeutic sensitivity of chronic myeloid leukemia to imatinib

Author：

E-ISSN： 1792-1082|10|5|2835-2841

ISSN： 1792-1074

Source： Oncology Letters, Vol.10, Iss.5, 2015-01, pp. : 2835-2841

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spautin-1, a novel autophagy inhibitor, enhances imatinib-induced apoptosis in chronic myeloid leukemia

International Journal of Oncology, Vol. 44, Iss. 5, 2014-01 ,pp. : 1661-1668

Spandidos Publications

Access to resources Recommend Favorite

Imatinib and chronic myeloid leukemia: close to the bone

By Terpos Evangelos

Leukemia and Lymphoma, Vol. 54, Iss. 8, 2013-08 ,pp. : 1581-1582

Informa Healthcare

Access to resources Recommend Favorite

慢性髓细胞白血病对伊马替尼产生耐药性的机制 Imatinib Resistance Mechanism on Chronic Myeloid Leukemia

By 夏君燕朱平

World Journal of Cancer Research, Vol. 02, Iss. 03, 2012-07 ,pp. : 15-19

汉斯出版社

Access to resources Recommend Favorite

Instability of mRNA expression signatures of drug transporters in chronic myeloid leukemia patients resistant to imatinib

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 741-750

Spandidos Publications

Access to resources Recommend Favorite

MicroRNA may predict the risk of relapse in acute myeloid leukemia

Future Oncology, Vol. 4, Iss. 3, 2008-06 ,pp. : 319-321

Future Medicine

Access to resources Recommend Favorite